Riis, Peter Theut
Saunte, Ditte Marie
Sigsgaard, Viktoria
Villani, Axel Patrice
Guillem, Philippe
Pascual, José C.
Kappe, Naomi N.
Vanlaerhoven, Annika M. J. D.
van der Zee, Hessel H.
Prens, Errol P.
El-Domyati, Moetaz
Abdel-Wahab, Hossam
Moftah, Nayera
Abdelghani, Rania
Agut-Busquet, Eugenia
Romaní, Jorge
Hlela, Carol
van den Worm, Lerinza
Bettoli, Vincenzo
Calamo, Giada
Gürer, Mehmet Ali
Beksaç, Burcu
Matusiak, Lukasz
Glowaczewska, Amelia
Szepietowski, Jacek C.
Emtestam, Lennart
Lapins, Jan
Kottb, Hassan Riad
Fatani, Mohammad
Weibel, Lisa
Theiler, Martin
Delage-Toriel, Maïa
Lam, Thi Thanh Hong
Nassif, Aude
Becherel, Pierre-Andre
Dolenc-Voljc, Mateja
Doss, Nejib
Bouazzi, Dorra
Benhadou, Farida
del Marmol, Veronique
Jemec, Gregor B. E.
Article History
Received: 28 September 2019
Accepted: 26 February 2020
First Online: 12 March 2020
Compliance with ethical standards
:
: Gregor B.E. Jemec: Honoraria from AbbVie, Leo pharma, Pierre-Fabre, and Novartis for participation on advisory boards. Grants from Abbvie, Novartis, Regeneron and Leo Pharma for participation as an investigator. Research grants from Abbvie, Leo Pharma and Novartis. Ditte Marie Saunte was paid as a consultant for advisory board meeting by AbbVie, Janssen and Sanofi. She received speaker’s honoraria and/or received grants from the following companies: Bayer, Abbvie, Desitin, Pfizer, Galderma, Astellas, Novartis, Sanofi, and Leo Pharma. José C. Pascual: Honoraria from Abbvie for participation on advisory boards. Jorge Romani: Honoraria from AbbVie, Leo pharma, Almirall and Novartis for participation on advisory boards. Lisa Weibel received honoraria for participation on advisory boards from Sanofi, Merz, and Pierre-Fabre; for participating as study investigator from Abbvie and Novartis; and speaker’s honoraria from Merz, Pierre Fabre, and MEDA Pharma. Philippe Guillem was paid as a consultant for advisory board meeting by AbbVie. He received as speaker’s honoraria from AbbVie, Convatech, and Cicaplus. Axel P Villani received honoraria for participation on advisory boards from Bailleul and Merck. Other Authors stated no conflict of interest.